You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Phase III study

Showing 9951 - 9975 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Volunteer Study Trial in San Antonio (CBP-4888, Placebo)

Recruiting
  • Healthy Volunteer Study
  • San Antonio, Texas
    Comanche Biopharma Clinical Research Site #1
Jun 1, 2023

Safety Issues, Tolerance Trial in Berlin (FC-12738, Saline)

Not yet recruiting
  • Safety Issues
  • Tolerance
  • Berlin, New Jersey
    Hassman Research Inc
Jul 31, 2023

Health, Subjective Trial in Seoul (ALT-BB4, 0.9%NaCl)

Completed
  • Health, Subjective
  • Seoul, Korea, Republic of
    Research Site
Dec 12, 2022

Systemic Lupus Erythematosus (SLE) Trial in China (SG301 SC Injection)

Recruiting
  • Systemic Lupus Erythematosus (SLE)
  • SG301 SC Injection
  • Bengbu, Anhui, China
  • +9 more
Nov 17, 2023

Anemia, Sickle Cell Trial in San Diego (HBI-002)

Not yet recruiting
  • Anemia, Sickle Cell
  • San Diego, California
    Contact Company
Nov 17, 2023

Healthy Trial in Anyang-si (DA-1229_01 5/1000mg (Before), DA-1229_01 5/1000mg (After))

Not yet recruiting
  • Healthy
  • DA-1229_01 5/1000mg (Before)
  • DA-1229_01 5/1000mg (After)
  • Anyang-si, Gyeonggi-do, Korea, Republic of
    Metro Hospital
Feb 13, 2023

Healthy Trial in Anyang-si (DA-1229_01 2.5/500mg (Before), DA-1229_01 2.5/500mg (After))

Not yet recruiting
  • Healthy
  • DA-1229_01 2.5/500mg (Before)
  • DA-1229_01 2.5/500mg (After)
  • Anyang-si, Gyeonggi-do, Korea, Republic of
    Metro Hospital
Feb 13, 2023

Healthy Trial in Anyang-si (DA-1229_01 5/1000mg (Before), DA-1229_01 5/1000mg (After))

Not yet recruiting
  • Healthy
  • DA-1229_01 5/1000mg (Before)
  • DA-1229_01 5/1000mg (After)
  • Anyang-si, Gyeonggi-do, Korea, Republic of
    Metro Hospital
Feb 13, 2023

Anesthesia, Fasting Trial in Bursa (group WM, group WR, Group AR)

Completed
  • Anesthesia
  • Fasting
  • group WM
  • +3 more
  • Bursa, Turkey
    Bursa Uludag University
Jul 31, 2023

NHL, NHL, Relapsed, Adult Trial in United States (CLN-978)

Recruiting
  • NHL
  • NHL, Relapsed, Adult
  • Birmingham, Alabama
  • +4 more
May 31, 2023

Amyloidosis; Systemic Trial in Woolloongabba, Box Hill (AT02)

Not yet recruiting
  • Amyloidosis; Systemic
  • Woolloongabba, Queensland, Australia
  • +1 more
Jul 11, 2023

Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma Trial in Seattle (autologous immunoglobulin

Completed
  • Refractory Multiple Myeloma
  • +3 more
  • autologous immunoglobulin idiotype-KLH conjugate vaccine
  • +3 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
May 2, 2019

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With

Completed
Has Results
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +35 more
  • PI3K inhibitor BKM120
  • cetuximab
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Sep 14, 2021

Solid Tumors, Advanced Solid Tumors, Metastatic Cancer Trial in Korea, Republic of (bevacizumab, erlotinib)

Recruiting
  • Solid Tumors
  • +2 more
  • Daejeon, Chungcheongnam-do, Korea, Republic of
  • +9 more
Jun 6, 2023

Glioma Trial in Boston (Supplemental High Fat Low Carbohydrate (sHFLC) + KetoPhyt)

Not yet recruiting
  • Glioma
  • Supplemental High Fat Low Carbohydrate (sHFLC) + KetoPhyt
  • Boston, Massachusetts
    Tufts Medical Center
Dec 8, 2022

Relapsing Multiple Sclerosis Trial in Fort Collins, Farmington (Ublituximab)

Recruiting
  • Relapsing Multiple Sclerosis
  • Ublituximab
  • Fort Collins, Colorado
  • +1 more
May 26, 2023

Hepatocellular Carcinoma, Advanced Cancer Trial in Charleston, Tainan, Taipei (Sorafenib, CVM-1118)

Terminated
  • Hepatocellular Carcinoma
  • Advanced Cancer
  • Charleston, South Carolina
  • +2 more
Jan 6, 2023

Kidney Transplantation Trial (SHR-2106 injection or )

Not yet recruiting
  • Kidney Transplantation
  • SHR-2106 injection or placebo
  • (no location specified)
Jul 9, 2023

Influenza Trial in Dresden, Freital (Fluarix™/Influsplit SSW®)

Completed
Has Results
  • Influenza
  • Fluarix™/Influsplit SSW®
  • Dresden, Sachsen, Germany
  • +5 more
Aug 22, 2018

Ovarian Cancer Trial in Copenhagen (APX005M)

Not yet recruiting
  • Ovarian Cancer
  • Copenhagen, Sjaelland, Denmark
    NSGO-CTU
Apr 19, 2022

Primary Biliary Cholangitis Trial in Canada (Emtricitabine (FTC)/Tenofovir Disoproxil (TDF), Raltegravir, Placebo Oral Capsule

Recruiting
  • Primary Biliary Cholangitis
  • Emtricitabine (FTC)/Tenofovir Disoproxil (TDF)
  • +2 more
  • Edmonton, Alberta, Canada
  • +5 more
Mar 15, 2022

Advanced Solid Tumor Trial (ZG0895 Hydrochloride for Injection)

Not yet recruiting
  • Advanced Solid Tumor
  • ZG0895 Hydrochloride for Injection
  • (no location specified)
May 25, 2023

Locally Advanced Unresectable or Metastatic Solid Tumors Trial in China (SG1906)

Recruiting
  • Locally Advanced Unresectable or Metastatic Solid Tumors
  • Beijing, Beijing, China
  • +8 more
May 12, 2023

Bladder Urothelial Carcinoma In Situ, Infiltrating Bladder Mixed Carcinoma, Stage 0a Bladder Cancer AJCC v8 Trial in Guam,

Recruiting
  • Bladder Urothelial Carcinoma In Situ
  • +4 more
  • Gemcitabine Hydrochloride
  • Pembrolizumab
  • Birmingham, Alabama
  • +379 more
Aug 23, 2022

Type 2 Diabetes, Glucose Tolerance Impaired, Insulin Sensitivity Trial in San Antonio (REMD-477, Placebo Subcutaneous injection)

Recruiting
  • Type 2 Diabetes
  • +2 more
  • San Antonio, Texas
    Texas Diabetes Institute
Dec 22, 2021